T1	Participants 947 999	95 randomized patients, 88 (93%) completed the study
T2	Participants 1201 1416	41 of the 49 patients (84%; 95% confidence interval, 70.4-92.7%) and 27 of the 46 patients (59%; 95% confidence interval, 43.3-73.0%) of the tetracycline- and clarithromycin-containing groups, respectively (P=0.007)
